InspireMD, Inc.
(NYSE Amex Equities : NSPR)

( )
NSPR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.15%427.741.0%$611.97m
ABTAbbott Laboratories 1.98%106.510.8%$553.89m
ISRGIntuitive Surgical, Inc. 0.00%693.162.4%$502.54m
DHRDanaher Corp. -0.05%209.690.7%$459.49m
MDTMedtronic Plc -0.03%103.600.6%$458.62m
BDXBecton, Dickinson & Co. 0.00%224.991.0%$391.59m
DXCMDexCom, Inc. 0.00%400.197.9%$332.41m
INOInovio Pharmaceuticals, Inc. -4.94%11.545.9%$324.67m
SYKStryker Corp. 0.20%207.091.3%$287.02m
BSXBoston Scientific Corp. 0.00%38.001.0%$286.72m
QDELQuidel Corp. 0.00%198.647.7%$263.05m
VARVarian Medical Systems, Inc. -0.01%171.939.1%$253.67m
BAXBaxter International, Inc. 0.05%79.581.8%$242.31m
ALGNAlign Technology, Inc. 0.00%322.866.4%$232.00m
EWEdwards Lifesciences Corp. 0.14%77.820.4%$224.51m

Company Profile

InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.